CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Altimmune Inc Company Snapshot
Altimmune Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Altimmune Inc with three other companies in this sector in the United States: Sarepta Therapeutics Incorporated (2016 sales of $5.42 million of which 100% was Grants & Research), Amicus Therapeutics, Inc ($4.96 million of which 100% was Biopharmaceutical), and Tetraphase Pharmaceuticals Inc ($5.15 million of which 100% was Biopharmaceuticals).

Sales Analysis. Altimmune Inc reported sales of $5.23 million for the year ending December of 2016. This represents a sharp decrease of 50.8% versus 2015, when the company's sales were $10.64 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Altimmune Inc
  Stock Performance Chart for Altimmune Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.96
(Figures in U.S. Dollars)
1 Week -3.4%   13 Weeks 21.7%  
4 Weeks -21.6%   52 Weeks -94.2%  
 
Altimmune Inc Key Data:
  Ticker: ALT Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 5,230,196
(Year Ending Jan 2017).
Employees: 13
  Currency: U.S. Dollars Market Cap: 30,679,174
  Fiscal Yr Ends: December Shares Outstanding: 15,652,640
  Share Type: Common Closely Held Shares: 4,091,016
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.